nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—CYP2C19—Ifosfamide—testicular cancer	0.108	0.346	CbGbCtD
Felbamate—CYP2E1—Etoposide—testicular cancer	0.0826	0.264	CbGbCtD
Felbamate—CYP3A4—Ifosfamide—testicular cancer	0.0524	0.167	CbGbCtD
Felbamate—CYP3A4—Vinblastine—testicular cancer	0.0278	0.0887	CbGbCtD
Felbamate—CYP3A4—Etoposide—testicular cancer	0.025	0.0799	CbGbCtD
Felbamate—CYP3A4—Doxorubicin—testicular cancer	0.0171	0.0545	CbGbCtD
Felbamate—Asthenia—Ifosfamide—testicular cancer	0.000439	0.000638	CcSEcCtD
Felbamate—Eosinophilia—Doxorubicin—testicular cancer	0.000436	0.000635	CcSEcCtD
Felbamate—Sweating—Methotrexate—testicular cancer	0.000435	0.000633	CcSEcCtD
Felbamate—Photosensitivity reaction—Epirubicin—testicular cancer	0.000434	0.000632	CcSEcCtD
Felbamate—Feeling abnormal—Cisplatin—testicular cancer	0.000434	0.000632	CcSEcCtD
Felbamate—Paraesthesia—Etoposide—testicular cancer	0.000433	0.000631	CcSEcCtD
Felbamate—Weight increased—Epirubicin—testicular cancer	0.000433	0.00063	CcSEcCtD
Felbamate—Pruritus—Ifosfamide—testicular cancer	0.000432	0.00063	CcSEcCtD
Felbamate—Haematuria—Methotrexate—testicular cancer	0.000432	0.000629	CcSEcCtD
Felbamate—Pancreatitis—Doxorubicin—testicular cancer	0.000432	0.000628	CcSEcCtD
Felbamate—Weight decreased—Epirubicin—testicular cancer	0.000431	0.000627	CcSEcCtD
Felbamate—Dyspnoea—Etoposide—testicular cancer	0.00043	0.000627	CcSEcCtD
Felbamate—Hyperglycaemia—Epirubicin—testicular cancer	0.000429	0.000625	CcSEcCtD
Felbamate—Somnolence—Etoposide—testicular cancer	0.000429	0.000625	CcSEcCtD
Felbamate—Epistaxis—Methotrexate—testicular cancer	0.000428	0.000623	CcSEcCtD
Felbamate—Pneumonia—Epirubicin—testicular cancer	0.000427	0.000621	CcSEcCtD
Felbamate—Nausea—Bleomycin—testicular cancer	0.000425	0.000618	CcSEcCtD
Felbamate—Vomiting—Dactinomycin—testicular cancer	0.000424	0.000617	CcSEcCtD
Felbamate—Agranulocytosis—Methotrexate—testicular cancer	0.000423	0.000616	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000421	0.000612	CcSEcCtD
Felbamate—Rash—Dactinomycin—testicular cancer	0.000421	0.000612	CcSEcCtD
Felbamate—Decreased appetite—Etoposide—testicular cancer	0.00042	0.000611	CcSEcCtD
Felbamate—Diarrhoea—Ifosfamide—testicular cancer	0.000418	0.000609	CcSEcCtD
Felbamate—Pancytopenia—Doxorubicin—testicular cancer	0.000418	0.000609	CcSEcCtD
Felbamate—Body temperature increased—Cisplatin—testicular cancer	0.000417	0.000606	CcSEcCtD
Felbamate—Fatigue—Etoposide—testicular cancer	0.000416	0.000606	CcSEcCtD
Felbamate—Jaundice—Epirubicin—testicular cancer	0.000414	0.000602	CcSEcCtD
Felbamate—Constipation—Etoposide—testicular cancer	0.000413	0.000601	CcSEcCtD
Felbamate—Pain—Etoposide—testicular cancer	0.000413	0.000601	CcSEcCtD
Felbamate—Urinary tract infection—Epirubicin—testicular cancer	0.000412	0.0006	CcSEcCtD
Felbamate—Conjunctivitis—Epirubicin—testicular cancer	0.000412	0.0006	CcSEcCtD
Felbamate—Dysuria—Doxorubicin—testicular cancer	0.000412	0.000599	CcSEcCtD
Felbamate—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000409	0.000596	CcSEcCtD
Felbamate—Haemoglobin—Methotrexate—testicular cancer	0.000409	0.000596	CcSEcCtD
Felbamate—Haemorrhage—Methotrexate—testicular cancer	0.000407	0.000593	CcSEcCtD
Felbamate—Hepatitis—Methotrexate—testicular cancer	0.000407	0.000593	CcSEcCtD
Felbamate—Sweating—Epirubicin—testicular cancer	0.000407	0.000592	CcSEcCtD
Felbamate—Haematuria—Epirubicin—testicular cancer	0.000405	0.000589	CcSEcCtD
Felbamate—Dizziness—Ifosfamide—testicular cancer	0.000404	0.000588	CcSEcCtD
Felbamate—Pharyngitis—Methotrexate—testicular cancer	0.000404	0.000588	CcSEcCtD
Felbamate—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000402	0.000585	CcSEcCtD
Felbamate—Weight increased—Doxorubicin—testicular cancer	0.000401	0.000583	CcSEcCtD
Felbamate—Epistaxis—Epirubicin—testicular cancer	0.0004	0.000583	CcSEcCtD
Felbamate—Weight decreased—Doxorubicin—testicular cancer	0.000398	0.00058	CcSEcCtD
Felbamate—Sinusitis—Epirubicin—testicular cancer	0.000398	0.00058	CcSEcCtD
Felbamate—Feeling abnormal—Etoposide—testicular cancer	0.000398	0.000579	CcSEcCtD
Felbamate—Hyperglycaemia—Doxorubicin—testicular cancer	0.000397	0.000578	CcSEcCtD
Felbamate—Nausea—Dactinomycin—testicular cancer	0.000396	0.000577	CcSEcCtD
Felbamate—Agranulocytosis—Epirubicin—testicular cancer	0.000396	0.000576	CcSEcCtD
Felbamate—Pneumonia—Doxorubicin—testicular cancer	0.000395	0.000575	CcSEcCtD
Felbamate—Gastrointestinal pain—Etoposide—testicular cancer	0.000395	0.000575	CcSEcCtD
Felbamate—Visual impairment—Methotrexate—testicular cancer	0.000392	0.000571	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000389	0.000567	CcSEcCtD
Felbamate—Vomiting—Ifosfamide—testicular cancer	0.000389	0.000566	CcSEcCtD
Felbamate—Bradycardia—Epirubicin—testicular cancer	0.000388	0.000565	CcSEcCtD
Felbamate—Rash—Ifosfamide—testicular cancer	0.000385	0.000561	CcSEcCtD
Felbamate—Dermatitis—Ifosfamide—testicular cancer	0.000385	0.000561	CcSEcCtD
Felbamate—Erythema multiforme—Methotrexate—testicular cancer	0.000385	0.00056	CcSEcCtD
Felbamate—Urticaria—Etoposide—testicular cancer	0.000383	0.000558	CcSEcCtD
Felbamate—Haemoglobin—Epirubicin—testicular cancer	0.000383	0.000557	CcSEcCtD
Felbamate—Jaundice—Doxorubicin—testicular cancer	0.000383	0.000557	CcSEcCtD
Felbamate—Rhinitis—Epirubicin—testicular cancer	0.000382	0.000556	CcSEcCtD
Felbamate—Abdominal pain—Etoposide—testicular cancer	0.000382	0.000556	CcSEcCtD
Felbamate—Body temperature increased—Etoposide—testicular cancer	0.000382	0.000556	CcSEcCtD
Felbamate—Urinary tract infection—Doxorubicin—testicular cancer	0.000382	0.000556	CcSEcCtD
Felbamate—Conjunctivitis—Doxorubicin—testicular cancer	0.000382	0.000556	CcSEcCtD
Felbamate—Haemorrhage—Epirubicin—testicular cancer	0.000381	0.000555	CcSEcCtD
Felbamate—Hepatitis—Epirubicin—testicular cancer	0.000381	0.000555	CcSEcCtD
Felbamate—Asthenia—Cisplatin—testicular cancer	0.000378	0.00055	CcSEcCtD
Felbamate—Pharyngitis—Epirubicin—testicular cancer	0.000378	0.00055	CcSEcCtD
Felbamate—Sweating—Doxorubicin—testicular cancer	0.000376	0.000548	CcSEcCtD
Felbamate—Haematuria—Doxorubicin—testicular cancer	0.000374	0.000545	CcSEcCtD
Felbamate—Epistaxis—Doxorubicin—testicular cancer	0.00037	0.000539	CcSEcCtD
Felbamate—Sinusitis—Doxorubicin—testicular cancer	0.000368	0.000536	CcSEcCtD
Felbamate—Visual impairment—Epirubicin—testicular cancer	0.000367	0.000534	CcSEcCtD
Felbamate—Agranulocytosis—Doxorubicin—testicular cancer	0.000366	0.000533	CcSEcCtD
Felbamate—Chills—Methotrexate—testicular cancer	0.000365	0.000532	CcSEcCtD
Felbamate—Nausea—Ifosfamide—testicular cancer	0.000363	0.000529	CcSEcCtD
Felbamate—Diarrhoea—Cisplatin—testicular cancer	0.000361	0.000525	CcSEcCtD
Felbamate—Erythema multiforme—Epirubicin—testicular cancer	0.00036	0.000524	CcSEcCtD
Felbamate—Alopecia—Methotrexate—testicular cancer	0.00036	0.000524	CcSEcCtD
Felbamate—Bradycardia—Doxorubicin—testicular cancer	0.000359	0.000522	CcSEcCtD
Felbamate—Haemoglobin—Doxorubicin—testicular cancer	0.000354	0.000516	CcSEcCtD
Felbamate—Flushing—Epirubicin—testicular cancer	0.000353	0.000515	CcSEcCtD
Felbamate—Rhinitis—Doxorubicin—testicular cancer	0.000353	0.000514	CcSEcCtD
Felbamate—Haemorrhage—Doxorubicin—testicular cancer	0.000352	0.000513	CcSEcCtD
Felbamate—Hepatitis—Doxorubicin—testicular cancer	0.000352	0.000513	CcSEcCtD
Felbamate—Pharyngitis—Doxorubicin—testicular cancer	0.00035	0.000509	CcSEcCtD
Felbamate—Dysgeusia—Methotrexate—testicular cancer	0.000347	0.000505	CcSEcCtD
Felbamate—Asthenia—Etoposide—testicular cancer	0.000346	0.000504	CcSEcCtD
Felbamate—Chills—Epirubicin—testicular cancer	0.000342	0.000498	CcSEcCtD
Felbamate—Pruritus—Etoposide—testicular cancer	0.000342	0.000497	CcSEcCtD
Felbamate—Visual impairment—Doxorubicin—testicular cancer	0.00034	0.000494	CcSEcCtD
Felbamate—Alopecia—Epirubicin—testicular cancer	0.000337	0.00049	CcSEcCtD
Felbamate—Vomiting—Cisplatin—testicular cancer	0.000335	0.000488	CcSEcCtD
Felbamate—Erythema multiforme—Doxorubicin—testicular cancer	0.000333	0.000485	CcSEcCtD
Felbamate—Rash—Cisplatin—testicular cancer	0.000332	0.000484	CcSEcCtD
Felbamate—Dermatitis—Cisplatin—testicular cancer	0.000332	0.000483	CcSEcCtD
Felbamate—Diarrhoea—Etoposide—testicular cancer	0.00033	0.000481	CcSEcCtD
Felbamate—Ill-defined disorder—Methotrexate—testicular cancer	0.000329	0.000479	CcSEcCtD
Felbamate—Anaemia—Methotrexate—testicular cancer	0.000327	0.000477	CcSEcCtD
Felbamate—Flushing—Doxorubicin—testicular cancer	0.000327	0.000476	CcSEcCtD
Felbamate—Flatulence—Epirubicin—testicular cancer	0.000327	0.000476	CcSEcCtD
Felbamate—Tension—Epirubicin—testicular cancer	0.000325	0.000474	CcSEcCtD
Felbamate—Dysgeusia—Epirubicin—testicular cancer	0.000325	0.000473	CcSEcCtD
Felbamate—Nervousness—Epirubicin—testicular cancer	0.000322	0.000469	CcSEcCtD
Felbamate—Malaise—Methotrexate—testicular cancer	0.00032	0.000465	CcSEcCtD
Felbamate—Dizziness—Etoposide—testicular cancer	0.000319	0.000465	CcSEcCtD
Felbamate—Leukopenia—Methotrexate—testicular cancer	0.000317	0.000462	CcSEcCtD
Felbamate—Chills—Doxorubicin—testicular cancer	0.000316	0.00046	CcSEcCtD
Felbamate—Nausea—Cisplatin—testicular cancer	0.000313	0.000456	CcSEcCtD
Felbamate—Alopecia—Doxorubicin—testicular cancer	0.000311	0.000453	CcSEcCtD
Felbamate—Cough—Methotrexate—testicular cancer	0.000309	0.00045	CcSEcCtD
Felbamate—Ill-defined disorder—Epirubicin—testicular cancer	0.000308	0.000448	CcSEcCtD
Felbamate—Vomiting—Etoposide—testicular cancer	0.000307	0.000447	CcSEcCtD
Felbamate—Anaemia—Epirubicin—testicular cancer	0.000306	0.000446	CcSEcCtD
Felbamate—Agitation—Epirubicin—testicular cancer	0.000305	0.000444	CcSEcCtD
Felbamate—Rash—Etoposide—testicular cancer	0.000304	0.000443	CcSEcCtD
Felbamate—Dermatitis—Etoposide—testicular cancer	0.000304	0.000443	CcSEcCtD
Felbamate—Headache—Etoposide—testicular cancer	0.000302	0.00044	CcSEcCtD
Felbamate—Flatulence—Doxorubicin—testicular cancer	0.000302	0.00044	CcSEcCtD
Felbamate—Chest pain—Methotrexate—testicular cancer	0.000302	0.000439	CcSEcCtD
Felbamate—Arthralgia—Methotrexate—testicular cancer	0.000302	0.000439	CcSEcCtD
Felbamate—Myalgia—Methotrexate—testicular cancer	0.000302	0.000439	CcSEcCtD
Felbamate—Tension—Doxorubicin—testicular cancer	0.000301	0.000438	CcSEcCtD
Felbamate—Dysgeusia—Doxorubicin—testicular cancer	0.0003	0.000437	CcSEcCtD
Felbamate—Malaise—Epirubicin—testicular cancer	0.000299	0.000435	CcSEcCtD
Felbamate—Discomfort—Methotrexate—testicular cancer	0.000298	0.000434	CcSEcCtD
Felbamate—Nervousness—Doxorubicin—testicular cancer	0.000298	0.000434	CcSEcCtD
Felbamate—Leukopenia—Epirubicin—testicular cancer	0.000297	0.000432	CcSEcCtD
Felbamate—Palpitations—Epirubicin—testicular cancer	0.000293	0.000427	CcSEcCtD
Felbamate—Confusional state—Methotrexate—testicular cancer	0.000292	0.000424	CcSEcCtD
Felbamate—Cough—Epirubicin—testicular cancer	0.000289	0.000421	CcSEcCtD
Felbamate—Anaphylactic shock—Methotrexate—testicular cancer	0.000289	0.000421	CcSEcCtD
Felbamate—Infection—Methotrexate—testicular cancer	0.000287	0.000418	CcSEcCtD
Felbamate—Nausea—Etoposide—testicular cancer	0.000287	0.000417	CcSEcCtD
Felbamate—Hypertension—Epirubicin—testicular cancer	0.000286	0.000417	CcSEcCtD
Felbamate—Ill-defined disorder—Doxorubicin—testicular cancer	0.000285	0.000414	CcSEcCtD
Felbamate—Anaemia—Doxorubicin—testicular cancer	0.000284	0.000413	CcSEcCtD
Felbamate—Thrombocytopenia—Methotrexate—testicular cancer	0.000283	0.000412	CcSEcCtD
Felbamate—Arthralgia—Epirubicin—testicular cancer	0.000282	0.000411	CcSEcCtD
Felbamate—Chest pain—Epirubicin—testicular cancer	0.000282	0.000411	CcSEcCtD
Felbamate—Myalgia—Epirubicin—testicular cancer	0.000282	0.000411	CcSEcCtD
Felbamate—Agitation—Doxorubicin—testicular cancer	0.000282	0.00041	CcSEcCtD
Felbamate—Anxiety—Epirubicin—testicular cancer	0.000281	0.00041	CcSEcCtD
Felbamate—Hyperhidrosis—Methotrexate—testicular cancer	0.00028	0.000407	CcSEcCtD
Felbamate—Discomfort—Epirubicin—testicular cancer	0.000279	0.000406	CcSEcCtD
Felbamate—Malaise—Doxorubicin—testicular cancer	0.000277	0.000403	CcSEcCtD
Felbamate—Dry mouth—Epirubicin—testicular cancer	0.000276	0.000402	CcSEcCtD
Felbamate—Anorexia—Methotrexate—testicular cancer	0.000276	0.000401	CcSEcCtD
Felbamate—Leukopenia—Doxorubicin—testicular cancer	0.000275	0.0004	CcSEcCtD
Felbamate—Confusional state—Epirubicin—testicular cancer	0.000273	0.000397	CcSEcCtD
Felbamate—Palpitations—Doxorubicin—testicular cancer	0.000271	0.000395	CcSEcCtD
Felbamate—Oedema—Epirubicin—testicular cancer	0.000271	0.000394	CcSEcCtD
Felbamate—Anaphylactic shock—Epirubicin—testicular cancer	0.000271	0.000394	CcSEcCtD
Felbamate—Hypotension—Methotrexate—testicular cancer	0.00027	0.000393	CcSEcCtD
Felbamate—Infection—Epirubicin—testicular cancer	0.000269	0.000391	CcSEcCtD
Felbamate—Cough—Doxorubicin—testicular cancer	0.000268	0.00039	CcSEcCtD
Felbamate—Thrombocytopenia—Epirubicin—testicular cancer	0.000265	0.000386	CcSEcCtD
Felbamate—Hypertension—Doxorubicin—testicular cancer	0.000265	0.000386	CcSEcCtD
Felbamate—Tachycardia—Epirubicin—testicular cancer	0.000264	0.000384	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000263	0.000384	CcSEcCtD
Felbamate—Hyperhidrosis—Epirubicin—testicular cancer	0.000262	0.000381	CcSEcCtD
Felbamate—Insomnia—Methotrexate—testicular cancer	0.000262	0.000381	CcSEcCtD
Felbamate—Myalgia—Doxorubicin—testicular cancer	0.000261	0.00038	CcSEcCtD
Felbamate—Arthralgia—Doxorubicin—testicular cancer	0.000261	0.00038	CcSEcCtD
Felbamate—Chest pain—Doxorubicin—testicular cancer	0.000261	0.00038	CcSEcCtD
Felbamate—Anxiety—Doxorubicin—testicular cancer	0.00026	0.000379	CcSEcCtD
Felbamate—Paraesthesia—Methotrexate—testicular cancer	0.00026	0.000378	CcSEcCtD
Felbamate—Discomfort—Doxorubicin—testicular cancer	0.000258	0.000376	CcSEcCtD
Felbamate—Anorexia—Epirubicin—testicular cancer	0.000258	0.000376	CcSEcCtD
Felbamate—Dyspnoea—Methotrexate—testicular cancer	0.000258	0.000375	CcSEcCtD
Felbamate—Somnolence—Methotrexate—testicular cancer	0.000257	0.000374	CcSEcCtD
Felbamate—Dry mouth—Doxorubicin—testicular cancer	0.000255	0.000372	CcSEcCtD
Felbamate—Dyspepsia—Methotrexate—testicular cancer	0.000255	0.000371	CcSEcCtD
Felbamate—Hypotension—Epirubicin—testicular cancer	0.000253	0.000368	CcSEcCtD
Felbamate—Confusional state—Doxorubicin—testicular cancer	0.000252	0.000368	CcSEcCtD
Felbamate—Decreased appetite—Methotrexate—testicular cancer	0.000251	0.000366	CcSEcCtD
Felbamate—Anaphylactic shock—Doxorubicin—testicular cancer	0.00025	0.000365	CcSEcCtD
Felbamate—Oedema—Doxorubicin—testicular cancer	0.00025	0.000365	CcSEcCtD
Felbamate—Fatigue—Methotrexate—testicular cancer	0.000249	0.000363	CcSEcCtD
Felbamate—Infection—Doxorubicin—testicular cancer	0.000249	0.000362	CcSEcCtD
Felbamate—Pain—Methotrexate—testicular cancer	0.000247	0.00036	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000247	0.000359	CcSEcCtD
Felbamate—Thrombocytopenia—Doxorubicin—testicular cancer	0.000245	0.000357	CcSEcCtD
Felbamate—Insomnia—Epirubicin—testicular cancer	0.000245	0.000356	CcSEcCtD
Felbamate—Tachycardia—Doxorubicin—testicular cancer	0.000244	0.000356	CcSEcCtD
Felbamate—Paraesthesia—Epirubicin—testicular cancer	0.000243	0.000354	CcSEcCtD
Felbamate—Hyperhidrosis—Doxorubicin—testicular cancer	0.000242	0.000352	CcSEcCtD
Felbamate—Dyspnoea—Epirubicin—testicular cancer	0.000241	0.000351	CcSEcCtD
Felbamate—Somnolence—Epirubicin—testicular cancer	0.000241	0.00035	CcSEcCtD
Felbamate—Anorexia—Doxorubicin—testicular cancer	0.000239	0.000347	CcSEcCtD
Felbamate—Feeling abnormal—Methotrexate—testicular cancer	0.000238	0.000347	CcSEcCtD
Felbamate—Dyspepsia—Epirubicin—testicular cancer	0.000238	0.000347	CcSEcCtD
Felbamate—Gastrointestinal pain—Methotrexate—testicular cancer	0.000236	0.000344	CcSEcCtD
Felbamate—Decreased appetite—Epirubicin—testicular cancer	0.000235	0.000342	CcSEcCtD
Felbamate—Hypotension—Doxorubicin—testicular cancer	0.000234	0.000341	CcSEcCtD
Felbamate—Fatigue—Epirubicin—testicular cancer	0.000233	0.00034	CcSEcCtD
Felbamate—Constipation—Epirubicin—testicular cancer	0.000231	0.000337	CcSEcCtD
Felbamate—Pain—Epirubicin—testicular cancer	0.000231	0.000337	CcSEcCtD
Felbamate—Urticaria—Methotrexate—testicular cancer	0.00023	0.000334	CcSEcCtD
Felbamate—Abdominal pain—Methotrexate—testicular cancer	0.000229	0.000333	CcSEcCtD
Felbamate—Body temperature increased—Methotrexate—testicular cancer	0.000229	0.000333	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000228	0.000332	CcSEcCtD
Felbamate—Insomnia—Doxorubicin—testicular cancer	0.000226	0.00033	CcSEcCtD
Felbamate—Paraesthesia—Doxorubicin—testicular cancer	0.000225	0.000327	CcSEcCtD
Felbamate—Dyspnoea—Doxorubicin—testicular cancer	0.000223	0.000325	CcSEcCtD
Felbamate—Feeling abnormal—Epirubicin—testicular cancer	0.000223	0.000325	CcSEcCtD
Felbamate—Somnolence—Doxorubicin—testicular cancer	0.000223	0.000324	CcSEcCtD
Felbamate—Gastrointestinal pain—Epirubicin—testicular cancer	0.000221	0.000322	CcSEcCtD
Felbamate—Dyspepsia—Doxorubicin—testicular cancer	0.00022	0.000321	CcSEcCtD
Felbamate—Decreased appetite—Doxorubicin—testicular cancer	0.000218	0.000317	CcSEcCtD
Felbamate—Fatigue—Doxorubicin—testicular cancer	0.000216	0.000314	CcSEcCtD
Felbamate—Urticaria—Epirubicin—testicular cancer	0.000215	0.000313	CcSEcCtD
Felbamate—Pain—Doxorubicin—testicular cancer	0.000214	0.000312	CcSEcCtD
Felbamate—Constipation—Doxorubicin—testicular cancer	0.000214	0.000312	CcSEcCtD
Felbamate—Body temperature increased—Epirubicin—testicular cancer	0.000214	0.000311	CcSEcCtD
Felbamate—Abdominal pain—Epirubicin—testicular cancer	0.000214	0.000311	CcSEcCtD
Felbamate—Asthenia—Methotrexate—testicular cancer	0.000207	0.000302	CcSEcCtD
Felbamate—Feeling abnormal—Doxorubicin—testicular cancer	0.000206	0.0003	CcSEcCtD
Felbamate—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000205	0.000298	CcSEcCtD
Felbamate—Pruritus—Methotrexate—testicular cancer	0.000205	0.000298	CcSEcCtD
Felbamate—Urticaria—Doxorubicin—testicular cancer	0.000199	0.00029	CcSEcCtD
Felbamate—Abdominal pain—Doxorubicin—testicular cancer	0.000198	0.000288	CcSEcCtD
Felbamate—Body temperature increased—Doxorubicin—testicular cancer	0.000198	0.000288	CcSEcCtD
Felbamate—Diarrhoea—Methotrexate—testicular cancer	0.000198	0.000288	CcSEcCtD
Felbamate—Asthenia—Epirubicin—testicular cancer	0.000194	0.000283	CcSEcCtD
Felbamate—Pruritus—Epirubicin—testicular cancer	0.000191	0.000279	CcSEcCtD
Felbamate—Dizziness—Methotrexate—testicular cancer	0.000191	0.000278	CcSEcCtD
Felbamate—Diarrhoea—Epirubicin—testicular cancer	0.000185	0.00027	CcSEcCtD
Felbamate—Vomiting—Methotrexate—testicular cancer	0.000184	0.000268	CcSEcCtD
Felbamate—Rash—Methotrexate—testicular cancer	0.000182	0.000265	CcSEcCtD
Felbamate—Dermatitis—Methotrexate—testicular cancer	0.000182	0.000265	CcSEcCtD
Felbamate—Headache—Methotrexate—testicular cancer	0.000181	0.000264	CcSEcCtD
Felbamate—Asthenia—Doxorubicin—testicular cancer	0.00018	0.000262	CcSEcCtD
Felbamate—Dizziness—Epirubicin—testicular cancer	0.000179	0.000261	CcSEcCtD
Felbamate—Pruritus—Doxorubicin—testicular cancer	0.000177	0.000258	CcSEcCtD
Felbamate—Vomiting—Epirubicin—testicular cancer	0.000172	0.00025	CcSEcCtD
Felbamate—Nausea—Methotrexate—testicular cancer	0.000172	0.00025	CcSEcCtD
Felbamate—Diarrhoea—Doxorubicin—testicular cancer	0.000171	0.000249	CcSEcCtD
Felbamate—Rash—Epirubicin—testicular cancer	0.000171	0.000248	CcSEcCtD
Felbamate—Dermatitis—Epirubicin—testicular cancer	0.00017	0.000248	CcSEcCtD
Felbamate—Headache—Epirubicin—testicular cancer	0.00017	0.000247	CcSEcCtD
Felbamate—Dizziness—Doxorubicin—testicular cancer	0.000166	0.000241	CcSEcCtD
Felbamate—Nausea—Epirubicin—testicular cancer	0.000161	0.000234	CcSEcCtD
Felbamate—Vomiting—Doxorubicin—testicular cancer	0.000159	0.000232	CcSEcCtD
Felbamate—Rash—Doxorubicin—testicular cancer	0.000158	0.00023	CcSEcCtD
Felbamate—Dermatitis—Doxorubicin—testicular cancer	0.000158	0.00023	CcSEcCtD
Felbamate—Headache—Doxorubicin—testicular cancer	0.000157	0.000228	CcSEcCtD
Felbamate—Nausea—Doxorubicin—testicular cancer	0.000149	0.000217	CcSEcCtD
